Your browser doesn't support javascript.
loading
Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target Proteins.
Inoue, Masa-Ki; Nakatsu, Yusuke; Yamamotoya, Takeshi; Hasei, Shun; Kanamoto, Mayu; Naitou, Miki; Matsunaga, Yasuka; Sakoda, Hideyuki; Fujishiro, Midori; Ono, Hiraku; Kushiyama, Akifumi; Asano, Tomoichiro.
Affiliation
  • Inoue MK; Department of Medical Science, Graduate School of Medicine, Hiroshima University, 1-2-3 Kasumi, Minamitnf-ku, Hiroshima City, Hiroshima 734-8551, Japan.
  • Nakatsu Y; Department of Medical Science, Graduate School of Medicine, Hiroshima University, 1-2-3 Kasumi, Minamitnf-ku, Hiroshima City, Hiroshima 734-8551, Japan.
  • Yamamotoya T; Department of Medical Science, Graduate School of Medicine, Hiroshima University, 1-2-3 Kasumi, Minamitnf-ku, Hiroshima City, Hiroshima 734-8551, Japan.
  • Hasei S; Department of Medical Science, Graduate School of Medicine, Hiroshima University, 1-2-3 Kasumi, Minamitnf-ku, Hiroshima City, Hiroshima 734-8551, Japan.
  • Kanamoto M; Department of Medical Science, Graduate School of Medicine, Hiroshima University, 1-2-3 Kasumi, Minamitnf-ku, Hiroshima City, Hiroshima 734-8551, Japan.
  • Naitou M; Department of Medical Science, Graduate School of Medicine, Hiroshima University, 1-2-3 Kasumi, Minamitnf-ku, Hiroshima City, Hiroshima 734-8551, Japan.
  • Matsunaga Y; Center for Translational Research in Infection & Inflammation, School of Medicine, Tulane University, 6823 St. Charles Avenue, New Orleans, LA 70118, USA.
  • Sakoda H; Division of Neurology, Respirology, Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan.
  • Fujishiro M; Division of Diabetes and Metabolic Diseases, Nihon University School of Medicine, Itabashi, Tokyo 173-8610, Japan.
  • Ono H; Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba 260-8670, Japan.
  • Kushiyama A; Department of Pharmacotherapy, Meiji Pharmaceutical University 2-522-1 Noshio Kiyose, Tokyo 204-8588, Japan.
  • Asano T; Department of Medical Science, Graduate School of Medicine, Hiroshima University, 1-2-3 Kasumi, Minamitnf-ku, Hiroshima City, Hiroshima 734-8551, Japan.
Cells ; 8(12)2019 11 29.
Article de En | MEDLINE | ID: mdl-31795496
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques / Prédisposition aux maladies / Stéatose hépatique non alcoolique / NIMA-interacting peptidylprolyl isomerase Type d'étude: Etiology_studies Limites: Animals / Humans Langue: En Journal: Cells Année: 2019 Type de document: Article Pays d'affiliation: Japon Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Marqueurs biologiques / Prédisposition aux maladies / Stéatose hépatique non alcoolique / NIMA-interacting peptidylprolyl isomerase Type d'étude: Etiology_studies Limites: Animals / Humans Langue: En Journal: Cells Année: 2019 Type de document: Article Pays d'affiliation: Japon Pays de publication: Suisse